HCA240816C365000
- 3.90
- +2.11+117.88%
HCA Healthcare Newsroom
HCA Healthcare Price Target Raised to $392.00/Share From $335.00 by Cantor Fitzgerald
Cantor Fitzgerald Reiterates Overweight on HCA Healthcare, Maintains $335 Price Target
HCA Healthcare Price Target Raised to $390.00/Share From $375.00 by Truist Securities
A Quick Look at Today's Ratings for HCA Healthcare(HCA.US), With a Forecast Between $340 to $397
Oppenheimer Maintains Outperform on HCA Healthcare, Raises Price Target to $390
HCA Healthcare Analyst Ratings
RBC Capital Reaffirms Their Buy Rating on HCA Healthcare (HCA)
Truist Adjusts Price Target on HCA Healthcare to $390 From $375, Maintains Buy Rating
HCA Healthcare: Strong Q2 Financials and Optimistic Outlook Justify Buy Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Biohaven Ltd. (BHVN), HCA Healthcare (HCA) and Kiniksa Pharmaceuticals (KNSA)
Buy Rating Affirmed for HCA Healthcare Amid Robust Growth and Positive Outlook
Analysts' Opinions Are Mixed on These Healthcare Stocks: HCA Healthcare (HCA), Oric Pharmaceuticals (ORIC) and GoodRx Holdings (GDRX)
Stephens Raises HCA Healthcare's Price Target to $375 From $360
HCA Healthcare: Strong Q2 Performance Meets Expectations, Maintains Hold Rating
HCA Healthcare: Steady Growth Prospects Lead to Hold Rating Amid Balanced Market Expectations
Bernstein Adjusts Price Target on HCA Healthcare to $362 From $317
HCA Healthcare (HCA) Receives a Buy From Bank of America Securities
Barclays Maintains Overweight on HCA Healthcare, Raises Price Target to $376
HCA Healthcare Analyst Ratings
HCA Healthcare (HCA) Receives a Buy From Barclays